Knowhow offering
|
| Title | Certolizumab pegol |
| Knowhow is available for | A method to produce the biosimilar: Certolizumab pegol |
| Summary | |
| Advantages | We produce Certolizumab by fermentation in the periplasm of E.coli in a native state with approx. yield of 250 mg/L (postcapturing purification step)
We developed the process for the synthesis of the branched PEG reagent for PEGylation of Certolizumab to obtain Certolizumab pegol, at gram scale with activity and purity > 95% ➢ Preparation of PEGylation reagent in around 10 g scale with yield of over 85%, purity of over 95% and activity of over 95% |
|
Knowhow is listed under following categories
|
Knowhow from
| |
| Scientific/ engineering subject areas |
Life sciences/ biosciences & engineering |
| Investor interest categories |
Biotechnology/ Biomedical/ Health Technologies |
| Industries |
Pharmaceuticals, Bulk Drugs, Formulations |
| Customer categories and nature of business |
Businesses and other industries (B2B) |
| Technology readiness levels
|
TRL B: Proof-of-concept demonstrated in lab scale |
|
Related documents:
|
|
|
|
Database reference
|
| Database record number |
20230315113704 |
| Date of upload |
16 / Mar / 2023 |
| Date of update |
|
| URL to site when communicating about this knowhow |
http://techex.in/khdb/viewrecord.php?recordno=20230315113704 |
| Request for this technology |
Click here for Request Form |
